Bleximenib

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

2 Sponsors

19 Countries

Phase III

Phase I

Phase I (Other)

Phase III: 2 Phase I: 1 Phase I (Other): 1

Sponsors using this IMP

Janssen - Cilag International 3 Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting 1

All trials

4 total

A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Phase III 14 countries Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
A Phase 1/2 Study of Bleximenib in Participants with Acute Leukemia Recruiting

2023-506581-31-00 Phase I 3 countries Janssen - Cilag International
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Phase III 12 countries Janssen Cilag International
A Phase 1b Study of Bleximenib in Combination with AML Directed Therapies for Participants with Acute Myeloid Leukemia Harboring KMT2A or NP… Ended

2023-506582-58-00 Phase I (Other) 4 countries Janssen - Cilag International

Showing 1–4 of 4 trials

← All drugs A–Z